DrugPatentWatch Database Preview
Investigational Drug Information for Andrographolide
Email this page to a colleague
What is the development status for investigational drug Andrographolide?
Andrographolide is an investigational drug.
There have been 9 clinical trials for Andrographolide.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2016.
The most common disease conditions in clinical trials are Multiple Sclerosis, Bronchitis, and Acute Disease. The leading clinical trial sponsors are University of Chile, Jiangxi Qingfeng Pharmaceutical Co. Ltd., and Universidad Austral de Chile.
There is one US patent protecting this investigational drug and seven international patents.
Summary for Andrographolide
| US Patents | 1,123 |
| International Patents | 7,664 |
| US Patent Applications | 2,486 |
| WIPO Patent Applications | 1,444 |
| Japanese Patent Applications | 776 |
| Clinical Trial Progress | Phase 2 (2016-12-01) |
| Vendors | 70 |
Recent Clinical Trials for Andrographolide
| Title | Sponsor | Phase |
|---|---|---|
| Efficacy of Ivermectin in COVID-19 | Bangkok Metropolitan Administration Medical College and Vajira Hospital | Phase 1/Phase 2 |
| To Compare the Efficacy and Tolerability of A. Paniculata/A. Chilensis in Individuals With URTI | Vedic Lifesciences Pvt. Ltd. | Phase 3 |
| HMPL004-6599 Phase I Dose-escalating Study | Hutchison Medipharma Limited | Phase 1 |
Clinical Trial Summary for Andrographolide
Top disease conditions for Andrographolide
Top clinical trial sponsors for Andrographolide
US Patents for Andrographolide
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Andrographolide | ⤷ Try it Free | Method of diagnosing and treating cancer using B-catenin splice variants | The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC) | ⤷ Try it Free |
| Andrographolide | ⤷ Try it Free | Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers | Celgene Corporation (Summit, NJ) The United States of America, as Represented by the Secretary, Department of Health and Human Services (Washington, DC) | ⤷ Try it Free |
| Andrographolide | ⤷ Try it Free | Use of inhibitors of Bruton'S tyrosine kinase (Btk) | Pharmacyclics LLC (Sunnyvale, CA) | ⤷ Try it Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Andrographolide
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Andrographolide | Australia | AU2006213610 | 2025-02-10 | ⤷ Try it Free |
| Andrographolide | Canada | CA2596845 | 2025-02-10 | ⤷ Try it Free |
| Andrographolide | Denmark | DK1851340 | 2025-02-10 | ⤷ Try it Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
